A federal securities class action has been filed against Picard Medical Inc., alleging the company and its executives made false or misleading statements and failed to disclose involvement in a fraudulent stock promotion scheme. The complaint claims insiders used offshore accounts to coordinate share dumping during a price inflation campaign and that key risks and trading activity were not properly disclosed. Picard Medical shares fell nearly 60 percent in a single day following these revelations. Investors who purchased shares between September 2, 2025, and October 31, 2025, have until April 13, 2026, to seek lead plaintiff status in the case.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Picard Medical Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202602160931NEWSFILECNPR____20260216_283903_1) on February 16, 2026, and is solely responsible for the information contained therein.